Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2025

Accounting Policies [Abstract]

Schedule of Percentage of Revenue and Accounts Receivable from Customers

Multiple customers have provided more than 10% of total revenue in the periods presented, or accounted for more than 10% of accounts receivable at each respective balance sheet date, as follows:

	Revenue				Accounts Receivable
	Three Months Ended September 30,		Nine Months Ended September 30,		September 30, 2025	December 31, 2024
	2025	2024	2025	2024
ModernaTX, Inc.	19%	33%	25%	28%	11%	*
Regeneron Pharmaceuticals	19%	*	*	*	19%	*
Pfizer Inc.	11%	*	*	*	12%	25%
Natera, Inc.	*	20%	10%	31%	*	13%
Merck & Co., Inc.	*	*	*	*	18%	31%
VA MVP	*	17%	15%	11%	*	*

* Less than 10% of revenue or accounts receivable.